Authors
Latest:
Wistar-Penn Collaboration Identifies HSP70 as Promising New Target for Melanoma TherapyA 10-year collaboration between scientists at The Wistar Institute and the University of Pennsylvania has recently resulted in the emergence of an exciting new target for cancer therapy, heat shock protein 70, that could be helpful in treating patients with melanoma.
Latest:
Dr. Ferrari on LBH589 and Bicalutamide in CRPCAnna C. Ferrari, MD, professor, co-director, GU Research Program, Departments of Medicine (Cancer Center) and Medicine (Residency Program), discusses a study that examined the efficacy of LBH589 and bicalutamide in patients with castration-resistant prostate cancer.
Latest:
Closing Thoughts on Intralesional Therapy for Melanoma and CSCCA panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.
Latest:
Dr. Farago on Frontline Immunotherapy Versus Maintenance Immunotherapy in SCLCAnna F. Farago, MD, PhD, medical oncologist at the Center for Thoracic Cancers at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses the use of frontline immunotherapy versus maintenance immunotherapy in patients with small cell lung cancer (SCLC).
Latest:
Dr. Farago on Opportunities to Investigate Biomarkers for Small Cell Lung CancerAnna Farago, MD, PhD, Massachusetts General Hospital Cancer Center, instructor of Medicine at Harvard Medical School, discusses opportunities for the development of biomarkers for patients with small cell lung cancer (SCLC).
Latest:
Palliative Care: Let’s Keep the Conversation OpenAs the end of my hematology/oncology fellowship draws near, I am reminded every day that oncology is not about winning or losing.
Latest:
The Goodwill of Strangers Helps Build a Unique Resource for Cancer ResearchThousands of women have made the selfless choice to literally donate a precious piece of themselves by giving a breast tissue sample to the Susan G. Komen Tissue Bank at the Indiana University Melvin and Bren Simon Cancer Center, a unique resource for researchers worldwide.
Latest:
Anna Vioral on Multidisciplinary Chemotherapy Safety StandardsAnna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.
Latest:
Dr Chiang on Frontline Treatment Combinations in ES-SCLCAnne Chiang, MD, PhD, discusses treatment options for patients with extensive-stage small cell lung cancer.
Latest:
Novel Treatment Approaches for SCLC and Future PerspectivesA panel of expert oncologists offer closing thoughts on the future treatment landscape and unmet needs in small-cell lung cancer.
Latest:
Dr. Covey on Recent and Future Changes to the NCCN Guidelines for HCCAnne Covey, MD, interventional radiologist, Memorial Sloan Kettering Cancer Center, discusses recent and future changes to locoregional treatment approaches for hepatocellular carcinoma (HCC).
Latest:
Dr. Favret on Extending Survival and Improving Outcomes in Breast CancerAnne Favret, MD, discusses the importance of clinical trials in the breast cancer space.
Latest:
Why Radiation Oncology Needs an APMAlternative payment models (APMs) are the future of Medicare payment.
Latest:
Dr. Klompenhouwer on the Resection of Larger Hepatocellular AdenomasAnne Julia Klompenhouwer, MD, Department of Surgery at Erasmus Medical Center in Rotterdam, The Netherlands, discusses when it is justified to resect a larger hepatocellular adenoma for patients with hepatocellular carcinoma (HCC).
Latest:
Anne Katz Discusses Cancer and SexualityAnne Katz, from the University of Manitoba, Discusses Cancer and Sexuality
Latest:
Supporting Adolescents and Young Adults With Cancer From Diagnosis Through SurvivorshipDue to the unique characteristics of adolescents and young adults, there is a growing effort to address their oncology needs.
Latest:
Dr. Anne Marie McCarthy on Measuring Breast Density with Computer AlgorithmsAnne Marie McCarthy, MD, research fellow, Massachusetts General Hospital, discusses using computer algorithms to measure breast density.
Latest:
Dr. McTiernan on Biomarkers in Breast CancerAnne McTiernan, MD, PhD, research professor of epidemiology, University of Washington, member, Fred Hutchinson Cancer Research Center, discusses the biomarkers that are associated with poor prognosis in patients with breast cancer.
Latest:
Dr. Odisho on a Risk Prediction Model in Renal Cell CarcinomaAnobel Odisho, MD, urologic oncology fellow, University of Washington, discusses the use of a risk prediction model for patients with renal cell carcinoma.
Latest:
The Personal Touch: Patients Are More Than Their ChartsAnthony Accurso, MD, offers a patient more time managing their cancer and a better quality of life.
Latest:
Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for unresectable hepatocellular carcinoma: a randomized, phase 3 trialDr. El-Khoueiry evaluates the efficacy and safety of camrelizumab in combination with rivoceranib for the treatment of unresecetable hepatocellular carcinoma in the front-line setting.
Latest:
Testing Reveals Extent of Lynch SyndromeThe presence of Lynch syndrome correlates with microsatellite-instability status and DNA mismatch-repair deficiency across a variety of tumor types.
Latest:
Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue SarcomasNeoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.
Latest:
Dr. Costales on Study of Adjuvant Therapy in Uterine LeiomyosarcomaAnthony Costales, MD, gynecologic oncology fellow, Cleveland Clinic, discusses a study of adjuvant therapy for patients with uterine leiomyosarcoma.
